Delivra Health Brands Inc. (OTCQB: DHBUF) (TSXV:DHB) announced that its wholly-owed subsidiary, Delivra Inc., has granted a subsidiary of Canopy Growth Corporation (NASDAQ: CGC), an exclusive strategic license agreement dated May, 23, 2023 to manufacture, distribute and sell infused LivRelief branded topicals in Canada.

"We are very pleased to announce our second agreement with Canopy, this time to secure more efficient and cost effective supply and distribution for our LivRelief infused branded topicals, such as the transdermal cream that ranked as the top selling …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.